ClinicalTrials.Veeva

Find clinical trials for Prostate Cancer in Roma, Lazio

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Recurrence
Adenocarcinoma
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near Roma, Lazio, ITA:

Transperineal Laser Ablation for Low- and Intermediate Risk Prostate Cancer: a Single Cohort Analysis

The goal of this prospective study is to test the efficacy of Echolaser transperineal focal therapy in patients with low- and intermediate risk prostate...

Enrolling
Prostate Cancer
Procedure: Soractelite Echolaser Transperineal focal laser ablation
San Carlo di Nancy Hospital

Roma, RM, Italy

docetaxel with or without local radiotherapy with or without abiraterone acetate and prednisone in patient with metastatic hormone-naïve prostate...

Active, not recruiting
Metastatic Prostate Cancer
Drug: Docetaxel
Radiation: radiotherapy

Phase 3

Unicancer
Unicancer

Roma, Italy and 76 other locations

patients with progressive metastatic castration-resistant prostate cancer (mCRPC).The following assessment of prostate cancer...

Active, not recruiting
Castration-resistant Prostate Cancer
Prostate Cancer Metastatic
Drug: HC-1119
Drug: Enzalutamide

Phase 3

Hinova Pharmaceuticals

Terni, Umbria, Italy and 57 other locations

therapy in participants with metastatic castration resistant prostate cancer (mCRPC). There will be ten cohorts in this study: Coho...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Drug: Enzalutamide 160 mg
Drug: Olaparib 400 mg

Phase 1, Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Rome, Italy and 32 other locations

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...

Enrolling
Prostate Cancer
Drug: prednisone
Drug: enzalutamide

Phase 2

Astellas
Astellas

Roma, Italy and 220 other locations

prednisone/prednisolone compared with placebo plus abiraterone and prednisone/prednisolone in participants with metastatic castrate-resistant prostate...

Active, not recruiting
Metastatic Prostate Cancer
Drug: Ipatasertib
Drug: Placebo

Phase 3

Roche
Roche

Roma, Lazio, Italy and 183 other locations

is to evaluate the effectiveness, safety and tolerability of nivolumab followed by ipilimumab, in subjects with metastatic castration resistant prostate...

Active, not recruiting
Prostate Cancer
Biological: Nivolumab
Biological: Ipilimumab

Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Terni, Italy and 58 other locations

hormonal therapy (NHT) in men with metastatic castration-resistant prostate cancer (mCRPC) who have previously been treated with on ...

Active, not recruiting
Metastatic Prostate Cancer
Prostate Adenocarcinoma
Drug: Cabozantinib
Drug: Abiraterone Acetate

Phase 3

Exelixis
Exelixis

Roma, Italy and 272 other locations

The intention of the study is to demonstrate superiority of Saruparib (AZD5305) + physician's choice NHA relative to placebo + physician's choice NHA...

Enrolling
Metastatic Castration-Sensitive Prostate Cancer
Drug: Abiraterone Acetate
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

Rome, Italy and 394 other locations

Researchers are looking for a better way to treat men at high-risk of biochemical recurrence (BCR) of prostate cancer.BCR means tha ...

Enrolling
Biochemically Recurrent Prostate Cancer
Other: Placebo matching darolutamide
Drug: Darolutamide (BAY1841788, Nubeqa)

Phase 3

Bayer
Bayer

Roma, Lazio, Italy and 258 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems